-
Posted by
Two Blokes Jun 29 -
Filed in
Stock
-
3 views
Procter & Gamble's relative outperformance is driven by margin gains and buybacks, but organic sales growth remains weak and barely outpaces inflation. The company commands a premium valuation with a 23x earnings multiple, yet top-line growth and earnings momentum are underwhelming in a high-rate environment. Dividend strength is notable, with a 69-year streak and a recent 5% increase, but payout ratios are rising as earnings growth is stagnating.
